fbpx
Web-Site-InteriorPage-Graphics-provider-news

New Practice Guidelines Released for the Administration of Buprenorphine for Treating Opioid Use Disorder

Provider Icon

The Department of Health and Human Services (HHS) have amended the practice guidelines for the administration of Buprenorphine for treating opioid use disorder: All prescribers with a valid state license and DEA can register for an X waiver without the mandatory training.

To sign up for the waiver:

https://buprenorphine.samhsa.gov/forms/select-practitioner-type.php

For more information about the new practice guidelines please visit the following websites:

HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder | HHS.gov

Federal Register :: Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder

 

California Bridge Program: Upcoming Zoom Waiver Training 

Date: May 21st

Time: 12-1PM PST

The big takeaway of the new HHS Practice Guidelines is that all prescribers with a valid state license and DEA can register for an X waiver without mandatory training. Our partners at the California Bridge Program offer prescribers support to “get waivered’ with some helpful tips and easy steps.

Given the unprecedented circumstances caused by COVID-19, Get Waivered Remote is offering a Zoom-based MAT Waiver training. Get Waivered Remote is a FREE course!

Eligible participants include:

  • MD,DO (Including Residents);
  • NP/PA (including NP/PA in training); and
  • Medical Students.

Register Here!

If you have any questions, please contact a Provider Relations Representative at (831) 430-5504.